Skip to Content
scroll

sigma/chemist warehouse reverse takeover

Our Q&As are emailed in our Saturday Morning Report, find the answer to this question below.

The Latest Q&A

Question asked

sigma/chemist warehouse reverse takeover

over some time i have bought sigma shares hoping [or gambling] of becoming a shareholder in the combined entity I note chanticleers comments on related party transactions but feel they will be overcome. I understand proposal depends on both companies shareholder approval plus final approval by the federal court presumably chemist warehouse financial details will be available at sigma meeting with documents to be issued in December my question is when it is likely that the proposal will be finalized and the rebranded company listed on the ASX? sigma are required to pay $700m, cash available to sigma at last balance date was approx $234m, where will further funds come from presumably another share issue by sigma. According to Stephen Mayne, last issue in jan 2024 treated small shareholders rather shabbily it would seem unlikely that a similar unpopular share issue would take place as it would be damaging to the ever growing reputation of the HMC man , the architect of this proposal Market Matters views on the above are requested many thanks

Answer

Hi Morrie,

Your purchase of SIG is likely to be looking great, the stocks roared higher over recent months.

The proposed merger between Sigma Healthcare and Chemist Warehouse is progressing, with the Australian Competition and Consumer Commission (ACCC) granting approval in early November 2024. The merger, valued at $8.8 billion, is expected to create a leading publicly-listed healthcare entity. The deal includes Sigma acquiring Chemist Warehouse shares in exchange for Sigma stock and $700 million in cash.

  • Listing the stock of the merged entity will likely follow the completion of these steps, potentially in late 2025. This timeline depends on the resolution of outstanding conditions and integration plans​.
  • As you say SIG plans to fund the acquisition of Chemist Warehouse using a combination of debt and equity financing, hence the balance would be largely debt funded. While details of the exact proportions of funding have not been disclosed, the company has indicated it is prepared for the financial requirements of the merger, i.e. no share issue.
chart
image description
Sigma Healthcare (SIG)
image description

Relevant suggested news and content from the site

Back to top